Concerns Over NHS Gender Identity Service Investigated

July 26, 2019

(Medscape) – The UK’s Health Research Authority (HRA) is investigating concerns raised by the BBC’s Newsnight programme about the NHS Gender Identity Development Service (GIDS) and early access to puberty blockers. The decision to prescribe the hormone blocking drugs is partly based on the results of a study, the design of which is now in question. Michael Biggs, associate professor of sociology at Oxford University, told the BBC he didn’t see how children and parents could have given informed consent for the drugs based on the “lack of information” provided.

Recommended Reading